Goldline Pharmaceutical SME logo

Goldline Pharmaceutical SME IPO Allotment Status

|Allotment Date: 15 May 2026|Listing Date: 19 May 2026|Listed

Goldline Pharmaceutical SME IPO closed on 14 May 2026. Allotment will be finalised on 15 May 2026. Refunds for unsuccessful applicants will be initiated on 16 May 2026. Shares will be credited to demat accounts on 16 May 2026. The stock lists on NSE and BSE on 19 May 2026.

Issue Price

Rs 43.00

Allotment Date

15 May 2026

Refund Date

16 May 2026

Share Credit Date

16 May 2026

Listing Date

19 May 2026

Registrar

Bigshare Services

GMP Today

Rs 15.00 (34.88%)

Est. Listing Price

Rs 58.00

Est. Profit / Lot

Rs 90,000.00

Goldline Pharmaceutical SME IPO Allotment Chances

Allotment odds below use application subscription (number of bids received), not share or amount subscribed.

Retail (IND)

  • Application subscription: 881.15x.
  • Allotment odds: about 1 in 881 (~1% chance per application).
  • Method: Lottery. If allotted, you receive at least one lot.
  • One application per PAN. Multiple eligible accounts in a household can improve overall family odds, not individual odds.

SHNI (Rs 2 lakh to Rs 10 lakh)

  • Application subscription: 952.21x.
  • Allotment odds: about 1 in 952 for a minimum-lot application (~1% of the applied lot on average).
  • Method: Proportional. Shares allotted are based on your bid size, not a lottery.
  • Share subscription was 995.84x. Allotment uses application count, not share volume.

BHNI (above Rs 10 lakh)

  • Application subscription: 704.45x.
  • Allotment odds: about 1 in 704 for a minimum-lot application (~1% of the applied lot on average).
  • Method: Proportional. Shares allotted are based on your bid size, not a lottery.
  • Share subscription was 1,995.67x. Allotment uses application count, not share volume.

Check the Goldline Pharmaceutical SME IPO Subscription Status for the full category-wise breakdown.

How to Check Goldline Pharmaceutical SME IPO Allotment Status

Allotment status will be available from 15 May 2026. There are four ways to check.

Option 1: Via IPOwiz App

  1. Download the IPOwiz App from the Play Store
  2. Add the PAN numbers you want to check in the PAN section
  3. Go to the Allotted section and select Goldline Pharmaceutical SME
  4. View the allotment status for the saved PAN numbers

Option 2: Via Bigshare Services Website

  1. Visit the Bigshare Services Allotment Page
  2. Select Goldline Pharmaceutical SME from the drop-down menu
  3. Enter your PAN number, application number, or demat account details
  4. Click Search to view your allotment status

Bigshare Services is the official registrar for this IPO. This is the most direct method to check your result.

Option 3: Via BSE Website

  1. Go to the BSE IPO allotment page
  2. Select Goldline Pharmaceutical SME from the list
  3. Enter your PAN number, application number, or demat account details
  4. Click Search to check your status

Option 4: Via Demat Account

Log in to your demat or trading account from 16 May 2026 onwards. If shares have been credited, your allotment was successful. Share credit is expected on 16 May 2026.

What Happens After Allotment?

Once allotment is finalised on 15 May 2026, the process moves as follows.

If you are allotted shares: Shares will be credited to your demat account on 16 May 2026. You can hold or sell on listing day, 19 May 2026. Based on current GMP of Rs 15.00, the estimated listing price is Rs 58.00 per share.

If you are not allotted shares: Your blocked amount (ASBA) will be unblocked and refunded on 16 May 2026. The refund goes back to the bank account linked to your application. UPI-based applications are unblocked automatically. ASBA applications through net banking are unblocked by your bank.

On listing day: The stock lists on NSE and BSE on 19 May 2026. You can sell your allotted shares from the moment trading begins.

For listing day updates, follow the IPOwiz Telegram Channel.

Goldline Pharmaceutical SME IPO Registrar Details

The registrar for this IPO is Bigshare Services. For allotment queries or discrepancies, you can contact them directly.

FieldValue
RegistrarBigshare Services Private Limited
Websitebigshareonline.com
Allotment CheckBigshare Services IPO Allotment Page
Emailipo@bigshareonline.com
Phone022-6263 8200 (toll free)

Goldline Pharmaceutical SME IPO Details

FieldValue
Price Band₹41.0 - ₹43.0
Issue Size₹11.61 Cr
Lot Size3000 shares
Minimum InvestmentRs 2,58,000.00
IPO TypeBSE SME
Open Date12 May 2026
Close Date14 May 2026
Allotment Date15 May 2026
Listing Date19 May 2026
Overall Subscription840.81x

Goldline Pharmaceutical SME IPO full details including financials, valuation, and review.

About Goldline Pharmaceutical SME

Goldline Pharmaceutical Limited, incorporated in 2021, is a pharmaceutical marketing company that operates under an asset-light business model. The company markets a wide range of pharmaceutical formulations under its proprietary brand 'Goldline', across five specialized divisions: Pharma (General), Cardinal (Specialty), Aayushman (Pediatric), InLife (Critical Care), and Wellness (Supportive Care). Instead of in-house manufacturing, Goldline partners with 15 third-party manufacturers and utilizes a network of 7 distributors to supply products to retailers and hospitals across Maharashtra, Tamil Nadu, Rajasthan, and other states.

Advertisement

Goldline Pharmaceutical SME IPO Allotment FAQs

What is Goldline Pharmaceutical SME IPO allotment date?

Goldline Pharmaceutical SME IPO allotment date is 15 May 2026. Allotment results are published by Bigshare Services on this date.

How to check Goldline Pharmaceutical SME IPO allotment status?

Check Goldline Pharmaceutical SME IPO allotment status on the Goldline Pharmaceutical SME IPO Allotment Status page on IPOwiz, on Bigshare Services (bigshareonline.com), BSE IPO allotment page, or the IPOwiz App using your PAN.

How to check Goldline Pharmaceutical SME IPO allotment by PAN?

Enter your PAN on Bigshare Services allotment portal (https://ipo.bigshareonline.com/IPO_Status.html), BSE IPO allotment, IPOwiz App, or the IPOwiz Goldline Pharmaceutical SME IPO Allotment Status page. Results are available from 15 May 2026.

When will Goldline Pharmaceutical SME IPO allotment result be announced?

Goldline Pharmaceutical SME IPO allotment result will be out on 15 May 2026, usually after market hours. Refunds for non-allotted applicants follow on 16 May 2026.

What are allotment chances in Goldline Pharmaceutical SME IPO for IND?

At 881.15x subscription by applications, approximately 1 in 881 ind applicants can expect an allotment (~1% per application). Allotment is by lottery.

When will Goldline Pharmaceutical SME IPO refund be credited?

If you are not allotted in Goldline Pharmaceutical SME IPO, your blocked ASBA amount is unblocked and refunded on 16 May 2026. UPI applications unblock automatically; net-banking ASBA is unblocked by your bank.

When will Goldline Pharmaceutical SME IPO shares be credited to demat?

Allotted Goldline Pharmaceutical SME IPO shares are credited to your demat account on 16 May 2026, one day before listing on 19 May 2026.

When is Goldline Pharmaceutical SME IPO listing date?

Goldline Pharmaceutical SME IPO listing date is 19 May 2026. The stock lists on NSE and BSE. You can sell allotted shares from the opening bell.

What to do if not allotted in Goldline Pharmaceutical SME IPO?

No action is needed. Your application amount is refunded on 16 May 2026 to the bank account linked to your IPO bid. You can apply in the next IPO.

How to check Goldline Pharmaceutical SME IPO allotment on BSE?

Visit the BSE IPO allotment page, select Goldline Pharmaceutical SME IPO, and enter your application number or PAN. Results go live on 15 May 2026 alongside the registrar website.

How to check Goldline Pharmaceutical SME IPO allotment on Bigshare Services?

Go to https://ipo.bigshareonline.com/IPO_Status.html, select Goldline Pharmaceutical SME IPO, and search by PAN or application number from 15 May 2026. For help, call 022-6263 8200 (toll free).

What is expected listing price of Goldline Pharmaceutical SME IPO?

Based on GMP of ₹15 (+34.88%), Goldline Pharmaceutical SME IPO expected listing price is about ₹58 per share (issue price ₹43 + GMP). Actual price is set on 19 May 2026.

What is Goldline Pharmaceutical SME IPO subscription status?

Final category-wise subscription for Goldline Pharmaceutical SME IPO is on the Goldline Pharmaceutical SME IPO Subscription Status page on IPOwiz, including QIB, NII, and IND figures.

Check your allotment status from 15 May 2026 on the IPOwiz Allotment Checker. For listing day updates on 19 May 2026, follow the IPOwiz Telegram Channel or download the IPOwiz App.

Reviewed by Dinesh Agrawal

15+ years in Indian capital markets and IPO research. Allotment guide verified before publish.